The purpose of this meeting is to discuss licensing topics associated with SHINE's proposed phased approach to construction and operation of its Medical Isotope Production Facility.

Purpose

* Meeting Canceled *

Meeting Dates and Times

09/22/22

Meeting Location

Webinar

Webinar Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_OGE1MzY3YjItMDA1ZS00OWI1LWI4ZmMtODkwYzExOGRhNmM2%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%227c83c4d7-517d-4abe-ae9e-9816f13e1059%22%7d

Contact

Michael Balazik

(301) 415-2856

Holly Cruz

(301) 415-1053

Participation Level

Observation

NRC Participants

Office of Nuclear Reactor Regulation

External Participants

SHINE Medical Technologies

Docket Numbers - Facility Names

05000608 - SHINE Medical Technologies, Inc.

Public Meeting Schedule: Meeting Details